Product analysis
Boron Complex 3 mg offers an inexpensive boron serving. The unknown balance and unclear identity of some sources make its likely absorption harder to judge.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality14
The blend includes boron aspartate alongside sources whose boron form is unclear. Unknown proportions prevent a confident judgment of its absorption quality.
Ingredient Transparency80
The total boron amount and listed sources are stated, making the basic serving identifiable. Their individual contributions are undisclosed, so the balance cannot be checked.
Value For Money100
The boron serving is favorably priced. Low cost does not resolve uncertainty about the mixed sources or expected benefit.
Customer Satisfaction82
Customer ratings are positive across a substantial set of reviews. The feedback describes satisfaction without establishing broader health benefits.
Product Focus50
Boron has a proposed role in mineral and bone metabolism, but routine broad-health benefits remain uncertain. The limited evidence does not establish a general benefit for healthy adults from this serving.
- Format
Capsule - Container
- 100 Capsule(s)
- Per serving
- $0.05
- Customer rating
- 4.5 · 2,436 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Boron Complex (Boron Aspartate, Citric Acid, Rice Protein) | 3 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability25
Boron Form & Bioavailability
Trademarked & High-Purity Sources
Dose, Safety & Label Transparency100
Elemental Dose Transparency
Dosage Efficacy & Safety Margin
Value100
Price per 3mg Elemental Boron
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of boron supplementation on the severity and duration of pain in primary dysmenorrhea.
- Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
- The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.
- Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
- Effects of Calcium Fructoborate on Levels of C-Reactive Protein, Total Cholesterol, Low-Density Lipoprotein, Triglycerides, IL-1β, IL-6, and MCP-1: a Double-blind, Placebo-controlled Clinical Study
- Biochemical and physiologic consequences of boron deprivation in humans.
- Plasma boron and the effects of boron supplementation in males.
- Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines